Home > Oncology > BCC 2019 > St. Gallen Consensus > Surgery of the axilla: indications decrease

Surgery of the axilla: indications decrease

Conference
BCC 2019
Trial
AMAROS
Next, the panel zoomed in on the benefit of (omitting) axillary surgery. Referring to the - recently updated - results of the AMAROS trial [1], suggesting equal outcomes between axillary surgery and axillary radiotherapy in terms of recurrence and/or disease-free survival but with less morbidity after radiotherapy, the majority of the panellists voted for omitting complementary axillary surgery as long as radiotherapy of the axilla and positive sentinel nodes was planned. This was the case both for patients (T1-2 with 1 or 2 positive sentinel nodes) who had undergone breast-conserving surgery (73% of the panellists voted for omitting axillary surgery) and patients who had a mastectomy (83% of the panellists voted for omitting axillary surgery). However, in case of patients with 1 or 2 positive sentinel nodes undergoing mastectomy and for whom no regional node irradiation was planned, 66% of the panellists voted against omitting axillary surgery. In addition, a majority (61%) of t...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on